Background: A recent study has shown that biomarkers relating to the variation of muscle strength with age exhibited gender differences. Objective: To discover whether gender differences in kyphosis and its progression with age might be explained in a related manner. Methods: Relevant aspects of muscular ageing, and related changes in the Cobb angle (a measure of kyphosis) were examined and linked to data on the gerontology of musculature. A hypothesis regarding embryonic antecedents was advanced. Results: Kyphosis appears to rest on a multifactorial basis, with age and muscular changes playing potentially important roles. Conclusions: The role of muscle strength as a cause of kyphosis merits further investigation. Both muscular and kyphotic studies should be repeated on the same subjects, and relevant embryonic antecedents be examined. A study of the relation between gonadal and antenatal muscular development might yield conclusive results.

Keywords:
Spine, Age-related changes, Bone mineral density, Aetiology, Gender, Muscle strength, Osteoporosis
This content is only available via PDF.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.